Mira L Katz PhD, MPH

Mira L Katz PhD, MPH
ProfessorCollege of Public Healthkatz.114@osu.edu
Suite 525 Gateway Building C 1590 N High Street Columbus Ohio 43201
Phone:614-293-6603Fax: 614-293-5611
  • Cancer Control

General Research Interest

Communication issues associated with cancer prevention and control

Research Description

Dr. Katz’s research focuses on communication issues associated with cancer prevention and control, with a concentration on improving the health of minority and underserved populations by informing and influencing decision making to improve an individual’s health.  Her current research projects focus on improving colon cancer screening rates and developing HPV vaccine educational interventions

Current Publications

  • Shoben AB, Katz MLCapsule commentary on price-haywood et Al., comparative effectiveness of audit-feedback versus additional physician communication training to improve cancer screening for patients with limited health literacy.J Gen Intern Med 29 1162 8/1/2014
  • McRee AL, Katz ML, Paskett ED, Reiter PLHPV vaccination among lesbian and bisexual women: Findings from a national survey of young adults.Vaccine in press 7/16/2014
  • Reiter PL, Brewer NT, Gilkey MB, Katz ML, Paskett ED, Smith JSEarly adoption of the human papillomavirus vaccine among Hispanic adolescent males in the United States.Cancer in press 6/19/2014
  • Katz ML, Oldach BR, Goodwin J, Reiter PL, Ruffin MT, Paskett EDDevelopment and initial feedback about a human papillomavirus (HPV) vaccine comic book for adolescents.J Cancer Educ 29 318-24 6/1/2014
  • Llanos AA, Pennell ML, Young GS, Tatum CM, Katz ML, Paskett EDNo association between colorectal cancer worry and screening uptake in Appalachian Ohio.J Public Health (Oxf) in press 5/20/2014
  • Reiter PL, Gupta K, Brewer NT, Gilkey MB, Katz ML, Paskett ED, Smith JSProvider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females.Cancer Epidemiol Biomarkers Prev 23 742-54 5/1/2014
  • Petrocy A, Katz MLCervical cancer and HPV: knowledge, attitudes, beliefs, and behaviors among women living in Guatemala.J Health Care Poor Underserved 25 624-36 5/1/2014
  • Carle AC, Jean-Pierre P, Winters P, Valverde P, Wells K, Simon M, Raich P, Patierno S, Katz M, Freund KM, Dudley D, Fiscella KPsychometric evaluation of the patient satisfaction with logistical aspects of navigation (PSN-L) scale using item response theory.Med Care 52 354-61 4/1/2014
  • Reiter PL, Oldach BR, Randle KE, Katz MLAcceptability of HPV vaccine for males and preferences for future education programs among Appalachian residents.Am J Mens Health 8 167-74 3/1/2014
  • Katz M, Young G, Pennell M, Reiter P, Paskett EAdherence to Multiple Cancer Screening Tests among Appalachian Women.Cancer Epidemiol Biomarkers Prev 23 564 3/1/2014
  • Oldach BR, Katz MLHealth literacy and cancer screening: a systematic review.Patient Educ Couns 94 149-57 2/1/2014
  • Manne S, Kashy D, Albrecht T, Wong YN, Lederman Flamm A, Benson AB, Miller SM, Fleisher L, Buzaglo J, Roach N, Katz M, Ross E, Collins M, Poole D, Raivitch S, Miller DM, Kinzy TG, Liu T, Meropol NJAttitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers.Eur J Cancer Care (Engl) in press 1/28/2014
  • Katz ML, Young GS, Reiter PL, Battaglia TA, Wells KJ, Sanders M, Simon M, Dudley DJ, Patierno SR, Paskett EDBarriers reported among patients with breast and cervical abnormalities in the patient navigation research program: impact on timely care.Womens Health Issues 24 e155-62 1/1/2014
  • Post DM, Shapiro CL, Cegala DJ, David P, Katz ML, Krok JL, Phillips GS, McAlearney AS, Lehman JS, Hicks W, Paskett EDImproving symptom communication through personal digital assistants: the CHAT (Communicating Health Assisted by Technology) project.J Natl Cancer Inst Monogr 2013 153-61 12/1/2013
  • Krieger JL, Katz ML, Eisenberg D, Heaner S, Sarge M, Jain PMedia coverage of cervical cancer and the HPV vaccine: implications for geographic health inequities.Health Expect 16 e1-12 9/1/2013
  • Francis SA, Katz MLThe HPV vaccine: a comparison of focus groups conducted in South Africa and Ohio Appalachia.Matern Child Health J 17 1222-9 9/1/2013
  • Jiang ZQ, Varadhachary G, Wang X, Kopetz S, Lee JE, Wang H, Shroff R, Katz M, Wolff RA, Fleming J, Overman MJA retrospective study of ampullary adenocarcinomas: overall survival and responsiveness to fluoropyrimidine-based chemotherapy.Ann Oncol 24 2349-53 9/1/2013
  • Paskett ED, Llanos AA, Young GS, Pennell ML, Lee CJ, Katz MLCorrelates of colorectal cancer screening among residents of Ohio Appalachia.J Community Health 38 609-18 8/1/2013
  • Katz ML, Ferketich AK, Paskett ED, Bloomfield CDHealth literacy among the Amish: measuring a complex concept among a unique population.J Community Health 38 753-8 8/1/2013
  • Reiter PL, Katz ML, Oliveri JM, Young GS, Llanos AA, Paskett EDValidation of self-reported colorectal cancer screening behaviors among Appalachian residents.Public Health Nurs 30 312-22 7/1/2013
  • Reiter PL, Katz ML, Paskett EDCorrelates of HPV vaccination among adolescent females from Appalachia and reasons why their parents do not intend to vaccinate.Vaccine 31 3121-5 6/28/2013
  • Murray DM, Katz ML, Post DM, Pennell ML, Young GS, Tatum CM, Paskett EDEnhancing cancer screening in primary care: rationale, design, analysis plan, and recruitment results.Contemp Clin Trials 34 356-63 3/1/2013
  • Reiter PL, Katz ML, Ruffin MT, Hade EM, DeGraffenreid CR, Patel DA, Paskett ED, Unger ERHPV prevalence among women from Appalachia: results from the CARE project.PLoS One 8 e74276 1/1/2013
  • Reiter PL, Katz ML, Ruffin MT, Hade EM, Degraffenreid CR, Patel DA, Paskett ED, Unger ERCorrection: HPV Prevalence among Women from Appalachia: Results from the CARE Project.PLoS One 8 1/1/2013
  • Reiter PL, Katz ML, Paskett EDHPV vaccination among adolescent females from Appalachia: implications for cervical cancer disparities.Cancer Epidemiol Biomarkers Prev 21 2220-30 12/1/2012
  • Oldach BR, Katz MLOhio Appalachia public health department personnel: human papillomavirus (HPV) vaccine availability, and acceptance and concerns among parents of male and female adolescents.J Community Health 37 1157-63 12/1/2012
  • Reiter PL, Broder-Oldach B, Wewers ME, Klein EG, Paskett ED, Katz MLAppalachian residents' perspectives on new U.S. cigarette warning labels.J Community Health 37 1269-78 12/1/2012
  • Paskett ED, Katz ML, Post DM, Pennell ML, Young GS, Seiber EE, Harrop JP, DeGraffinreid CR, Tatum CM, Dean JA, Murray DM, Ohio Patient Navigation Research ProgramThe Ohio Patient Navigation Research Program: does the American Cancer Society patient navigation model improve time to resolution in patients with abnormal screening tests?Cancer Epidemiol Biomarkers Prev 21 1620-8 10/1/2012
  • Katz ML, Archer LE, Peppercorn JM, Kereakoglow S, Collyar DE, Burstein HJ, Schilsky RL, Partridge AHPatient advocates' role in clinical trials: perspectives from Cancer and Leukemia Group B investigators and advocates.Cancer 118 4801-5 10/1/2012
  • Katz ML, Broder-Oldach B, Fisher JL, King J, Eubanks K, Fleming K, Paskett EDPatient-provider discussions about colorectal cancer screening: who initiates elements of informed decision making?J Gen Intern Med 27 1135-41 9/1/2012
  • Ruffin MT, Hade EM, Gorsline MR, DeGraffinreid CR, Katz ML, Kobrin SC, Paskett EDHuman papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio.Vaccine 30 5349-57 8/3/2012

The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James) 300 W. 10th Ave. Columbus, OH 43210 Phone: 1-800-293-5066 | Email: jamesline@osumc.edu